Clinical Trial

Current Survey on Chemotherapy-Related Myelosuppression and Clinical Management in Chinese County-level Tumor Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 16, 2024 (before its estimated October 20, 2025 completion). Its status may not reflect the trial's current state.
Summary
Current Survey on Chemotherapy-Related Myelosuppression and Clinical Management in Chinese County-level Tumor Patients
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-10-12.
Trial Details
NCT Number NCT06641934
Lead Sponsor The First Affiliated Hospital of Xinxiang Medical College
Collaborators: Xinxiang Central Hospital of Henan province, Linzhou People Hospital, Inner Huang County Traditional Chinese Hospital, Changyuan People Hospital, Huojia County People Hospital, Huojia County Alliance Hospital, Qinyang People Hospital, Xinan County People Hospital, Henan Hongli Hospital, Army Hospital of the 83rd Army, Anyang Cancer Hospital, Puyang Hospital of Traditional Chinese Medicine, Puyang Huimin Hospital, Hebi People Hospital, The Second People Hospital of Xinxiang Henan
Conditions Myelosuppression
Enrollment 1,000 participants
Start Date 2024-10-20
Primary Completion 2025-10-20 (estimated)
Study Completion 2025-12-20 (estimated)
Updated on ClinicalTrials.gov 2024-10-16